It can achieve this by preserving the viability of glioma stem cells (GSCs), recruiting Tumor-Associated Macrophages (TAMs), and inducing the exhaustion of CD8+ T cells and NK cells [13,14,15,16]. This evidence concerns the gene CD8A and neoplasm.